BackWeLeader Biomedical , Ltd. Overview

WeLeader Biomedical , Ltd. Long Term Debt

Track WeLeader Biomedical , Ltd.'s long-term debt ($870M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$868.87M
↑ 42.00% YoYΔ $257.01M vs prior year quarter

Peer trimmed avg / median

Loading

WeLeader Biomedical , Ltd. Long Term Debt History

Loading

WeLeader Biomedical , Ltd. vs. peers: Long Term Debt Comparison

Loading

WeLeader Biomedical , Ltd. Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

WeLeader Biomedical , Ltd. (7713.TWO) FAQ

The latest long-term debt for 7713.TWO is $870M as of June 2026. That compares with $610M in the prior-year period — up 42.0% year over year. Investors often review this figure alongside WeLeader Biomedical , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 7713.TWO's long-term debt moved from $610M to $870M — a 42.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in WeLeader Biomedical , Ltd.'s operating scale or balance-sheet position.

A long-term debt figure of $870M for 7713.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 7713.TWO's long-term debt ($870M), review year-over-year change from $610M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.